CPRX vs PPL · P/E 18, rev $491.7M vs P/E 22, rev $9.04B
Catalyst Pharmaceuticals Inc (CPRX) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported PPL revenue for 2025-12-31 was $9.04B. Net income was $1.18B. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the CPRX and PPL stock pages for the full models.
Not investment advice.